Clinical Trial Update: Synergistic Anti-tumor Effect of ChangTai Keli for Colon Cancer Patients [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial of ChangTai Keli for colon cancer with current status not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• ChangTai Keli

Snippet

Sponsor: Nanjing NingQi Medicine Science and Technology Co., Ltd. | Conditions: Colon Cancer | Phase 2, Phase 3 | Status: UNKNOWN